Dong Socio Holding Ltd.
Dong-A Socio Holdings, a Korean pharma manufacturer, offers a diversified portfolio from over-the-counter meds to biosimilars, with Phase III drugs like DA‑8010 (overactive bladder) and DMB‑3115 (Stelara biosimilar) poised for global expansion.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.